Report Overview
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis.
The global Midostaurin Drugs market size was estimated at USD 127.50 million in 2023 and is projected to reach USD 96.93 million by 2032, exhibiting a CAGR of -0.03 during the forecast period.
North America Midostaurin Drugs market size was estimated at USD 31.54 million in 2023, at a CAGR of -0.03 during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Midostaurin Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Midostaurin Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Midostaurin Drugs market in any manner.
Global Midostaurin Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Market Segmentation (by Type)
AML
MDS
Other
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Midostaurin Drugs Market
Overview of the regional outlook of the Midostaurin Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Midostaurin Drugs
1.2 Key Market Segments
1.2.1 Midostaurin Drugs Segment by Type
1.2.2 Midostaurin Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Midostaurin Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Midostaurin Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Midostaurin Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Midostaurin Drugs Market Competitive Landscape
3.1 Global Midostaurin Drugs Sales by Manufacturers (2019-2025)
3.2 Global Midostaurin Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Midostaurin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Midostaurin Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Midostaurin Drugs Sales Sites, Area Served, Product Type
3.6 Midostaurin Drugs Market Competitive Situation and Trends
3.6.1 Midostaurin Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Midostaurin Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Midostaurin Drugs Industry Chain Analysis
4.1 Midostaurin Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Midostaurin Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Midostaurin Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Midostaurin Drugs Sales Market Share by Type (2019-2025)
6.3 Global Midostaurin Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Midostaurin Drugs Price by Type (2019-2025)
7 Midostaurin Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Midostaurin Drugs Market Sales by Application (2019-2025)
7.3 Global Midostaurin Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Midostaurin Drugs Sales Growth Rate by Application (2019-2025)
8 Midostaurin Drugs Market Consumption by Region
8.1 Global Midostaurin Drugs Sales by Region
8.1.1 Global Midostaurin Drugs Sales by Region
8.1.2 Global Midostaurin Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Midostaurin Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Midostaurin Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Midostaurin Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Midostaurin Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Midostaurin Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Midostaurin Drugs Market Production by Region
9.1 Global Production of Midostaurin Drugs by Region (2019-2025)
9.2 Global Midostaurin Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Midostaurin Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Midostaurin Drugs Production
9.4.1 North America Midostaurin Drugs Production Growth Rate (2019-2025)
9.4.2 North America Midostaurin Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Midostaurin Drugs Production
9.5.1 Europe Midostaurin Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Midostaurin Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Midostaurin Drugs Production (2019-2025)
9.6.1 Japan Midostaurin Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Midostaurin Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Midostaurin Drugs Production (2019-2025)
9.7.1 China Midostaurin Drugs Production Growth Rate (2019-2025)
9.7.2 China Midostaurin Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novartis
10.1.1 Novartis Midostaurin Drugs Basic Information
10.1.2 Novartis Midostaurin Drugs Product Overview
10.1.3 Novartis Midostaurin Drugs Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Midostaurin Drugs SWOT Analysis
10.1.6 Novartis Recent Developments
11 Midostaurin Drugs Market Forecast by Region
11.1 Global Midostaurin Drugs Market Size Forecast
11.2 Global Midostaurin Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Midostaurin Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Midostaurin Drugs Market Size Forecast by Region
11.2.4 South America Midostaurin Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Midostaurin Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Midostaurin Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Midostaurin Drugs by Type (2025-2032)
12.1.2 Global Midostaurin Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Midostaurin Drugs by Type (2025-2032)
12.2 Global Midostaurin Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Midostaurin Drugs Sales (K MT) Forecast by Application
12.2.2 Global Midostaurin Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Midostaurin Drugs Market Size Comparison by Region (M USD)
Table 5. Global Midostaurin Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Midostaurin Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Midostaurin Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Midostaurin Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Midostaurin Drugs as of 2022)
Table 10. Global Market Midostaurin Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Midostaurin Drugs Sales Sites and Area Served
Table 12. Manufacturers Midostaurin Drugs Product Type
Table 13. Global Midostaurin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Midostaurin Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Midostaurin Drugs Market Challenges
Table 22. Global Midostaurin Drugs Sales by Type (K MT)
Table 23. Global Midostaurin Drugs Market Size by Type (M USD)
Table 24. Global Midostaurin Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Midostaurin Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Midostaurin Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Midostaurin Drugs Market Size Share by Type (2019-2025)
Table 28. Global Midostaurin Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Midostaurin Drugs Sales (K MT) by Application
Table 30. Global Midostaurin Drugs Market Size by Application
Table 31. Global Midostaurin Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Midostaurin Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Midostaurin Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Midostaurin Drugs Market Share by Application (2019-2025)
Table 35. Global Midostaurin Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Midostaurin Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Midostaurin Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Midostaurin Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Midostaurin Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Midostaurin Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Midostaurin Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Midostaurin Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Midostaurin Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Midostaurin Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Midostaurin Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Midostaurin Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Midostaurin Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Midostaurin Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Midostaurin Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Midostaurin Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Novartis Midostaurin Drugs Basic Information
Table 52. Novartis Midostaurin Drugs Product Overview
Table 53. Novartis Midostaurin Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Novartis Business Overview
Table 55. Novartis Midostaurin Drugs SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Global Midostaurin Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 58. Global Midostaurin Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 59. North America Midostaurin Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 60. North America Midostaurin Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 61. Europe Midostaurin Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 62. Europe Midostaurin Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 63. Asia Pacific Midostaurin Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 64. Asia Pacific Midostaurin Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 65. South America Midostaurin Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 66. South America Midostaurin Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 67. Middle East and Africa Midostaurin Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 68. Middle East and Africa Midostaurin Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 69. Global Midostaurin Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 70. Global Midostaurin Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 71. Global Midostaurin Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 72. Global Midostaurin Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 73. Global Midostaurin Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Midostaurin Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Midostaurin Drugs Market Size (M USD), 2019-2032
Figure 5. Global Midostaurin Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Midostaurin Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Midostaurin Drugs Market Size by Country (M USD)
Figure 11. Midostaurin Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Midostaurin Drugs Revenue Share by Manufacturers in 2023
Figure 13. Midostaurin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Midostaurin Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Midostaurin Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Midostaurin Drugs Market Share by Type
Figure 18. Sales Market Share of Midostaurin Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Midostaurin Drugs by Type in 2023
Figure 20. Market Size Share of Midostaurin Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Midostaurin Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Midostaurin Drugs Market Share by Application
Figure 24. Global Midostaurin Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Midostaurin Drugs Sales Market Share by Application in 2023
Figure 26. Global Midostaurin Drugs Market Share by Application (2019-2025)
Figure 27. Global Midostaurin Drugs Market Share by Application in 2023
Figure 28. Global Midostaurin Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Midostaurin Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Midostaurin Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Midostaurin Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Midostaurin Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Midostaurin Drugs Sales Market Share by Country in 2023
Figure 37. Germany Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Midostaurin Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Midostaurin Drugs Sales Market Share by Region in 2023
Figure 44. China Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Midostaurin Drugs Sales and Growth Rate (K MT)
Figure 50. South America Midostaurin Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Midostaurin Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Midostaurin Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Midostaurin Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Midostaurin Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Midostaurin Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Midostaurin Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Midostaurin Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Midostaurin Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Midostaurin Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Midostaurin Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Midostaurin Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Midostaurin Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Midostaurin Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Midostaurin Drugs Market Share Forecast by Application (2025-2032)
